Centene Corp

In a Stage 2 advancing environment, CNC remains medium- and long-term bullish but is consolidating around the converged 9/20/50 EMA cluster with overbought RSI and Options Score. Short-term price is pulling back into EMAs without clear conviction, so execution is deferred—stalk pullbacks into the EMA zone for optimal entry.

• ↑Q2 revenue $44.4 B, 13% above estimates; net income $1.09 B.
• ↑Adjusted EPS $2.51 beat; FY26 EPS guidance raised >$4.80.
• ↓Medicaid membership fell to 12.1 M; forecasted down 8–9% Y/Y.